Minerva Neurosciences Inc.

NERV | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.69

+$0.03 (+0.82%)

At close: Sep 21, 2026, 4:00 PM ET

$3.70

+$0.01 (+0.27%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.82%

(1D)

Rating

Updated: Sep 19, 2026

21.8

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $171.68M

1D Range

3.64 3.78

52W Range

2.01 12.46

Valuation (TTM)

PE -0.13

PB -0.00

EV/EBITDA 6.79

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $10

Cash Flow

FCF Yield -10938.6%

SBC Adj. FCF Yield -17336.2%

SBC Impact -58.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -115.1% | -35.3%

FCF 3Y | 5Y -149.6% | -99.4%

Returns

ROA -414.7%

ROE 250.0%

ROIC -38.6%

Financial Health

Net Cash

$75.27B

Current Ratio 20.14

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders af...

Sector Healthcare

Industry Biotechnology

Employees 7

IPO Date Jun 30, 2014

Website www.minervaneurosciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$10

Upside

+171.00%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞